
Gregg Polansky
Examiner (ID: 370, Phone: (571)272-9070 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1621, 1629, 1609, 1611, 1614 |
| Total Applications | 861 |
| Issued Applications | 392 |
| Pending Applications | 11 |
| Abandoned Applications | 462 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14227181
[patent_doc_number] => 20190125763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/226061
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16226061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/226061 | Non-hormonal steroid modulators of NF-kB for treatment of disease | Dec 18, 2018 | Issued |
Array
(
[id] => 14099065
[patent_doc_number] => 20190091208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 16/198242
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/198242 | USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | Nov 20, 2018 | Abandoned |
Array
(
[id] => 14069253
[patent_doc_number] => 20190083514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Vitamin D Composition
[patent_app_type] => utility
[patent_app_number] => 16/195214
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/195214 | Vitamin D composition | Nov 18, 2018 | Issued |
Array
(
[id] => 17256697
[patent_doc_number] => 20210369682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => [2-[(5-NITRO-1,3-THIAZOL-2-YL)CARBAMOYL]PHENYL]ETHANOATE FOR USE IN LYMPHANGIOLEIOMYOMATOSIS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/764861
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764861 | [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate for use in lymphangioleiomyomatosis and other diseases | Nov 18, 2018 | Issued |
Array
(
[id] => 14069157
[patent_doc_number] => 20190083466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS TO IMPROVE BEEF QUALITY
[patent_app_type] => utility
[patent_app_number] => 16/194652
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194652
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/194652 | NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS TO IMPROVE BEEF QUALITY | Nov 18, 2018 | Abandoned |
Array
(
[id] => 15405229
[patent_doc_number] => 20200022936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => COMBINATIONS OF DICLOFENAC, H2 RECEPTOR ANTAGONISTS AND ALKALI METAL BICARBONATES FOR THE TREATMENT OF PAIN AND INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/497571
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497571
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497571 | COMBINATIONS OF DICLOFENAC, H2 RECEPTOR ANTAGONISTS AND ALKALI METAL BICARBONATES FOR THE TREATMENT OF PAIN AND INFLAMMATION | Nov 15, 2018 | Abandoned |
Array
(
[id] => 16450923
[patent_doc_number] => 20200360349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => ADMINISTRATION OF MONOBACTAM FOR THE TREATMENT OF URINARY TRACT INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/762204
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762204 | ADMINISTRATION OF MONOBACTAM FOR THE TREATMENT OF URINARY TRACT INFECTION | Nov 8, 2018 | Abandoned |
Array
(
[id] => 18028885
[patent_doc_number] => 11512057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Unsaturated hydrocarbon pyrimidine thioether compounds and preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/615080
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11736
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615080 | Unsaturated hydrocarbon pyrimidine thioether compounds and preparation method and application thereof | Nov 4, 2018 | Issued |
Array
(
[id] => 15338825
[patent_doc_number] => 10525068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Anti-inflammatory properties of marine lipid compositions
[patent_app_type] => utility
[patent_app_number] => 16/180564
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 17295
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16180564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/180564 | Anti-inflammatory properties of marine lipid compositions | Nov 4, 2018 | Issued |
Array
(
[id] => 16367855
[patent_doc_number] => 10799590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Compositions containing a bitter tastant and at least one sophorolipid, and methods of reducing bitter taste attributed to a bitter tastant in an edible composition
[patent_app_type] => utility
[patent_app_number] => 16/174570
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21320
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/174570 | Compositions containing a bitter tastant and at least one sophorolipid, and methods of reducing bitter taste attributed to a bitter tastant in an edible composition | Oct 29, 2018 | Issued |
Array
(
[id] => 15990225
[patent_doc_number] => 20200170983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METHODS FOR THE TREATMENT OF BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 16/166305
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166305
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166305 | METHODS FOR THE TREATMENT OF BLADDER CANCER | Oct 21, 2018 | Abandoned |
Array
(
[id] => 14806169
[patent_doc_number] => 20190269694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/157672
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 142099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157672 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | Oct 10, 2018 | Abandoned |
Array
(
[id] => 16275494
[patent_doc_number] => 10758501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents
[patent_app_type] => utility
[patent_app_number] => 16/149892
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6859
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16149892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/149892 | Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents | Oct 1, 2018 | Issued |
Array
(
[id] => 14210581
[patent_doc_number] => 20190117675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => Compositions And Methods To Treat And/Or Prevent Vision Disorders Of The Lens Of The Eye
[patent_app_type] => utility
[patent_app_number] => 16/147840
[patent_app_country] => US
[patent_app_date] => 2018-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16147840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/147840 | Compositions And Methods To Treat And/Or Prevent Vision Disorders Of The Lens Of The Eye | Sep 29, 2018 | Abandoned |
Array
(
[id] => 13837293
[patent_doc_number] => 20190022131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => PHARMACEUTICAL FORMULATIONS USEFUL FOR INHIBITING ACID SECRETION AND METHODS FOR MAKING AND USING THEM
[patent_app_type] => utility
[patent_app_number] => 16/138859
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138859 | PHARMACEUTICAL FORMULATIONS USEFUL FOR INHIBITING ACID SECRETION AND METHODS FOR MAKING AND USING THEM | Sep 20, 2018 | Abandoned |
Array
(
[id] => 15751239
[patent_doc_number] => 10617702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Concentrated therapeutic phospholipid compositions
[patent_app_type] => utility
[patent_app_number] => 16/135212
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 13516
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16135212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/135212 | Concentrated therapeutic phospholipid compositions | Sep 18, 2018 | Issued |
Array
(
[id] => 13837189
[patent_doc_number] => 20190022079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => METHOD OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/131772
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131772 | Method of treating prostate cancer | Sep 13, 2018 | Issued |
Array
(
[id] => 14231135
[patent_doc_number] => 20190127740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases
[patent_app_type] => utility
[patent_app_number] => 16/127638
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127638 | Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases | Sep 10, 2018 | Abandoned |
Array
(
[id] => 13823783
[patent_doc_number] => 20190015376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => ANTIPARASITIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/049033
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/049033 | Antiparasitic compositions and methods | Jul 29, 2018 | Issued |
Array
(
[id] => 13519395
[patent_doc_number] => 20180311240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/028365
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028365 | METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISEASES | Jul 4, 2018 | Abandoned |